Tue.Nov 21, 2023

article thumbnail

Unveiling Progress and Challenges: C diff Awareness Among Medical Professionals

Pharmacy Times

Christian John Lillis, co-founder and executive director at Peggy Lillis Foundation, discusses the role of the pharmacist in education that advances C diff awareness in the medical community.

158
158
article thumbnail

Moderna loses a COVID vaccine patent in Europe amid heated clash with BioNTech, Pfizer

Fierce Pharma

With litigation spanning many countries, the COVID-19 vaccine giants remain engaged in a heated patent war. | Moderna pledged to appeal after the European Patent Office ruled one of its patents invalid in the intellectual property battle that spans multiple countries.

Vaccines 145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharmacists Can Educate Patients About Smoking Cessation Technology Options

Pharmacy Times

Free apps can help patients track cravings, monitor triggers, and stay motivated

154
154
article thumbnail

Invisible in the data: Broad ‘Asian American’ category obscures health disparities

STAT

They have roots in 50 countries that cover more than half of the globe’s surface. They make up more than 60% of the world’s population. They speak more than 100 different languages. Yet in medical research and public health in the United States, people with Asian ancestry are almost always grouped into a single racial category. Nearly 25 million Americans — from Hmong to Laotians, and Koreans to Indonesians — have been given the same label by the U.S. government despi

Labelling 145
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Prevention, Treatment for Migraine Rapidly Evolves, Calling for Development of Novel Drugs

Pharmacy Times

Zavegepant (Zavzpret; Pfizer) is the first and only only CGRP receptor antagonist as a nasal spray for the acute treatment of migraine in adults with and without aura approved by the FDA.

FDA 153
article thumbnail

Racial Discrimination in Cancer Care Setting Impacts Black Patients Long-Term

Drug Topics

Black patients reported associating negative emotions with experiences of racial discrimination long after the experience concluded, raising concerns about long-term health outcomes.

144
144

More Trending

article thumbnail

How the shakeup at OpenAI underscores the need for AI standards in health care

STAT

The leadership turmoil within OpenAI, the maker of ChatGPT, is triggering calls for stepped-up efforts to establish standards for how generative AI is used across the health care industry, where experts worry that one or two companies could end up with too much control. Microsoft was already a driving force behind efforts to deploy generative AI in health care.

144
144
article thumbnail

Texas AG sues Pfiz­er and Tris Phar­ma for adul­ter­at­ed ADHD drug

Pharmaceutical Technology

Texas AG has sued Pfizer and Tris Pharma for providing adulterated attention-deficit/hyperactivity disorder drug, Quillivant XR, to children.

141
141
article thumbnail

Opinion: Filling 12-month prescriptions is one practical way to help the pharmacist crisis

STAT

Pharmacies could be called the most “rock solid” entity in our health care system. Even before Covid, pharmacies were held in high esteem; during the pandemic, they raised their game by making it easy for tens of millions of Americans to get vaccinated, fulfilling a long-standing ambition of pharmacists to provide more expansive clinical services.

Vaccines 143
article thumbnail

Extended-Release Buprenorphine Found Well-Tolerated for Fentanyl Opioid Use Disorder

Pharmacy Times

Eligible individuals with opioid use disorder using fentanyl received a single 4 mg dose of transmucosal buprenorphine followed by the extended-release buprenorphine 300 mg injection after approximately 1 hour.

139
139
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Opinion: What Rosalynn Carter understood about mental health

STAT

Few people leave the world with as much grace or influence as Rosalynn Smith Carter, who died Sunday at the age of 96. While she called her autobiography “The First Lady of Plains,” to many she was also the first lady of mental health reform. Decades ago, she took bold stances on mental health topics that, today, have become conventional wisdom: Mental health is health, stigma is deadly, and people with mental illness deserve to be part of society instead of hidden away in overcrow

143
143
article thumbnail

With filing in Sanofi and Mylan insulin lawsuit, FTC amps up scrutiny on pharma's patent tactics

Fierce Pharma

The U.S. Federal Trade Commission isn’t letting up in its effort to crack down on pharma’s alleged misuse of a patent mechanism in the FDA’s regulatory process. | The U.S. Federal Trade Commission isn't letting up in its effort to crack down on pharma's alleged misuse of a patent mechanism in the FDA's regulatory process. And it's Sanofi’s turn to land in the crosshairs.

FDA 136
article thumbnail

STAT+: Delay of eye drop recall highlights FDA’s impotence on the issue

STAT

WASHINGTON — It took nearly three weeks for a maker of eye drops to recall its products after the Food and Drug Administration requested a recall. There have been no reports of injuries, but some key lawmakers are arguing the time it took the FDA to coax a voluntary recall shows the agency should be given the power to force them. Eye drops must be sterile because drugs applied to eyes bypass some of the body’s natural defenses.

FDA 135
article thumbnail

How Prisma Health unified digital health tech to boost patient engagement, slash no-shows

Fierce Healthcare

Navigating the healthcare system often requires using different websites, mobile apps and phone calls to find providers and make appointments. | The health system has seen a 10x increase in downloads of the Prisma Health Go app, from 40 to up to 400 downloads per day. The health system also reports a 33% reduction in patient no-shows in one year and estimates $8 million in cost savings as a result of slashing the no-show rates.

135
135
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

STAT+: How the CEO of the largest medical device accelerator molds medtech startups

STAT

If Paul Grand weren’t the CEO of MedTech Innovator, the largest medical device accelerator in the world, he might have been a keychain salesman. Maybe a producer of the X-Files. Or even invented Quizlet. The son of a teacher and a dentist, Grand graduated from selling neighbors keychains and washing cars as a little kid to programming software that made his parents’ lives easier.

134
134
article thumbnail

Texas accuses Pfizer and contract manufacturer of providing ineffective ADHD drug to state's Medicaid program

Fierce Pharma

Texas has accused Pfizer and manufacturer Tris Pharma of knowingly providing compromised ADHD medicine to a state Medicaid program for children of low-income families. | In its lawsuit, Texas says the companies knew that deficient manufacturing processes compromised the effectiveness of Quillivant XR. The lawsuit further accuses the companies of manipulating quality-control testing from 2012 to 2018 to ensure samples received passing grades.

132
132
article thumbnail

Keeping Our Infant and Older Adult Populations RSV-Free This Season

Pharmacy Times

It will be interesting to see RSV hospitalization rates over this upcoming season following the rollout of RSV vaccines and monoclonal antibody administration.

Vaccines 130
article thumbnail

Why Medicare Advantage is lacking on cancer care

Fierce Healthcare

A City of Hope analysis found that Medicare Advantage members faced a delay of two weeks or more between diagnosis and their first course of therapy.

126
126
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

10 folate-rich foods

The Checkup by Singlecare

Folic acid is the synthetic form of vitamin B9 often added to processed food products like cereal and multivitamin supplements. In its naturally occurring form, vitamin B9 is called folate. “ Folic acid plays a critical role in our health by promoting the formation of new, healthy red blood cells, which are vital for oxygen transportation in our bodies,” says Kelsey Costa , MS, RDN, a registered dietitian and nutrition consultant for Consumer Health Digest.

article thumbnail

Talkspace inks $26M contract with NYC to provide free mental health services to teens

Fierce Healthcare

Online therapy company Talkspace with provide free virtual mental health services to more than 400,000 adolescents and teens in New York City. | Talkspace CEO Jon Cohen, M.D. believes the company has a "moral imperative" to help address teen mental health. There's also a smart business case for building out its virtual mental health offerings for adolescents and teens.

126
126
article thumbnail

GSK aims to slash carbon emissions with next-generation inhaler

Fierce Pharma

Joining drugmakers like AstraZeneca and Novo Nordisk, GSK is making big strides in its quest to clean up its carbon footprint. | GSK plans to start late-stage trials of a low-carbon version of its metered dose inhaler (MDI) Ventolin utilizing a next-generation propellant in 2024. If the new product proves successful, it has the potential to slash greenhouse gas emissions from Ventolin use by roughly 90%.

122
122
article thumbnail

STAT+: Mixed study results for MorphoSys blood-cancer drug raise questions about approval

STAT

LONDON — An experimental blood cancer drug from MorphoSys hit its primary target in a pivotal trial, the company announced late Monday, but the drug faltered in addressing patient symptoms, causing the company’s stock to fall in early Tuesday trading. In the Phase 3 trial, the German company was testing its drug candidate pelabresib combined with the drug Jakafi against a Jakafi-placebo duo in patients with newly diagnosed myelofibrosis, a type of rare blood cancer.

121
121
article thumbnail

Wound care manufacturer controversy calls attention to shady dealings

Fierce Healthcare

Legacy Medical Consultants, a wound care manufacturer, is under fire for its business practices that critics say are another example of companies in the industry exploiting the Medicare system. | An independent investigation has shed light on one wound care manufacturer's rebate scheme that puts the onus on providers to report payments correctly.

117
117
article thumbnail

STAT+: Flagship Pioneering launches Quotient, a new biotech, in two countries

STAT

Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom. Quotient, which was founded last year and had operated in stealth mode, wants to develop drugs that target illnesses caused by genetic changes that occur as people age.

article thumbnail

Publix names new executive chairman, CEO and president

Drug Store News

Effective Jan. 1, CEO Todd Jones will become executive chairman, President Kevin Murphy will be promoted to CEO and Senior Vice President John Goff will be promoted to president.

116
116
article thumbnail

New NICE Advice service

pharmaphorum

New NICE Advice service Mike.

116
116
article thumbnail

GSK propels its progress to Net Zero

European Pharmaceutical Review

Phase III trials of a low carbon version of GSK’s metered dose inhaler, Ventolin (salbutamol), using a next generation, lower carbon propellant, are set to start in 2024. The pharma company stated that if successful, it has the potential to reduce greenhouse gas emissions from use of the inhaler by approximately 90 percent. According to GSK, thirty-five million patients with respiratory conditions globally relying on its metered dose inhaler.

116
116
article thumbnail

GSK says new inhaler will help slash its carbon footprint

pharmaphorum

GSK says new inhaler will help slash its carbon footprint Phil.

116
116
article thumbnail

Bayer's trial flop, courtroom setback could restrict CEO's options amid strategic review: analyst

Fierce Pharma

After suffering setbacks in the clinic and in court over the last week, Bayer’s ability to overhaul its corporate structure is becoming more constricted, one group of analysts contends. | After suffering setbacks in the clinic and in court this week, Bayer’s ability to overhaul its corporate structure is becoming more constricted, one group of analysts contends.

116
116
article thumbnail

Digital measures for value-based healthcare: Current perspectives

pharmaphorum

Digital measures for value-based healthcare: Current perspectives Mike.

115
115
article thumbnail

Poor Environmental Quality Associated With Higher Rates of Breast Cancer

Drug Topics

In counties with poor land quality, particularly urban counties, there was a higher incidence of early-stage disease and total breast cancer.

112
112
article thumbnail

Immunometabolism: Providing a new era of targeted medicine

pharmaphorum

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Neil Weir, CEO of Sitryx Therapeutics, a smaller biotech that specialises in immunometabolism – a rapidly emerging and exciting area of investigation into the role of intracellular metabolic pathways in immune cells.

article thumbnail

Lost in the mix of Medicaid 'unwinding': Kentucky cut off her healthcare over a clerical error

Fierce Healthcare

The day her Medicaid coverage ended, Beverly Likens was in the hospital after a scary trip to the emergency room. | Millions of people nationwide have lost Medicaid benefits after a pandemic-era mandate for coverage expired in March—most of them for administrative reasons unrelated to their actual eligibility.

Hospitals 111